CClinicalTrials.gg
RecruitingNCT05879861Updated May 30, 2023

Development and Validation of a Risk Prediction Model for Preoperative Frailty in Elderly Patients With Colorectal Cancer

An observational study in Colorectal Cancer, sponsored by Zunyi Medical College. Recruiting at 1 site in China. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2023-05-30.

Sponsored by Zunyi Medical College · Observational

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
  • Started Aug 2022; still recruiting 4 years 2 months later.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
364
Ages
60 Years and older
Sex
All
01

Study summary

Fried Scale and its related scales were used to analyze the status and risk factors of preoperative frailty in elderly patients with colorectal cancer. R software was used to construct a risk prediction model for preoperative frailty in elderly patients with colorectal cancer, and its validity and stability were verified in clinical practice.

02

Conditions studied

  • Colorectal Cancer
03

In context

Colorectal Neoplasms

5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's planned enrollment of 364 is above the median of 250 across 1,226 observational studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

Zunyi Medical College is the lead sponsor of 20 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients who met the diagnostic criteria of colorectal cancer in Chinese Guidelines for Diagnosis and Treatment of Colorectal Cancer 2020 Edition and underwent surgery.

Inclusion criteria

  1. patients who met the diagnostic criteria of colorectal cancer in Chinese Guidelines for Diagnosis and Treatment of Colorectal Cancer 2020 Edition and underwent surgery;
  2. patients aged ≥60 years old ;
  3. patients who are clearly conscious, able to understand instructions, communicate normally, and complete the physical activity ability test without the assistance of others;
  4. patients who gave informed consent and volunteered to participate in the study.

Exclusion criteria

Exclusion Criteria:

  1. patients with limb joint disease and lower limb pain;
  2. patients with serious heart, liver, kidney diseases could not complete the test;
  3. patients with visual impairment and hearing impairment;
  4. patients with a history of mental illness or drug dependence;
  5. taking antidepressants, levodopa/carbidopa, donepezil hydrochloride and other drugs ;
  6. patients who received preoperative radiotherapy and chemotherapy;
  7. Patients with hypothyroidism, Parkinson's disease, stroke and other diseases.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
364 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Status of frailty

    Status of frailty will be assessed by Fried Scale

    Time frame: 1 day

07

Study locations

1 of 1 sites recruiting
  • Yongmei Zhang
    Zunyi, Guizhou 563000, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 30, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05879861
Lead sponsor
Zunyi Medical College
Responsible party
Yongmei Zhang (Study Director, Zunyi Medical College) — Principal investigator
First posted
May 30, 2023
Start date
Aug 1, 2022
Primary completion
Jul 31, 2025 (estimated)
Completion
Jul 31, 2025 (estimated)
Last update
May 30, 2023

Study contacts

Yongmei Zhang
Contact
hulizym@yeah.net
13885257269
Yongmei Zhang
study director · Zunyi Medical College

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion